Sunil Healthcare Ltd (SUNLOC) is currently trading at 70.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sunil Healthcare Limited manufactures Empty Hard Gelatin Capsule (EHGC) shells and HPMC capsule shells, operating a WHO‑GMP certified facility in Alwar and exporting globally; it also runs a food division branded Sunloc Foods and holds wholly owned subsidiaries in North America and Mexico to support international distribution and group expansion efforts. The company approved unaudited standalone and consolidated results for Q2/H1 FY25‑26 which were reviewed by Singhi & Co. with no modifications; the auditor noted the foreign subsidiaries’ results are immaterial to the Group, underlining that consolidated reporting is complete while overseas operations remain small relative to the parent. Sunil Healthcare has scaled capacity over many years with incremental additions—increasing production from hundreds of millions to about 15 billion capsules per annum by 2023‑24—evidencing a strategic focus on manufacturing scale, export readiness and product mix expansion including HPMC capsules introduced in 2018. The business is diversifying into food ingredients (Sunloc Foods) sourcing raw cashew nuts and other nuts from West Africa and beyond; this vertical adds a new commodity and supply‑chain profile to the company, introducing both cross‑sell opportunities and incremental supply chain and working capital complexity.

Over the past 52 weeks, Sunil Healthcare Ltd has traded between a low of ₹56.35 and a high of ₹82.31. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sunil Healthcare Ltd has a market capitalization of approximately 71.78. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sunil Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.50 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 71.78 Cr, Sunil Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sunil Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sunil Healthcare Ltd is 19.50. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.